Quick Answer
SPRUCE BIOSCIENCES, INC. reported Diluted EPS of $50.83 per share (loss) for fiscal year 2025.
SPRUCE BIOSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$50.83 | +47.3% |
| 2024 | -$96.40 | -7674.2% |
| 2023 | -$1.24 | +36.7% |
| 2022 | -$1.96 | -8.3% |
| 2021 | -$1.81 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.58 | +7.4% | -316.6% |
| June 30, 2025 | -$3.50 | +79.1% | -993.8% |
| March 31, 2025 | -$0.32 | -14.3% | +98.0% |
| September 30, 2024 | -$15.75 | -5150.0% | +5.9% |
| June 30, 2024 | -$16.73 | -5128.1% | -5875.0% |
| March 31, 2024 | -$0.28 | +30.0% | +6.7% |
| September 30, 2023 | -$0.30 | +37.5% | +6.3% |
| June 30, 2023 | -$0.32 | +37.3% | +20.0% |
- SPRUCE BIOSCIENCES, INC. showed an increase of +47.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, SPRUCE BIOSCIENCES, INC.’s diluted eps has declined by 2708.3% (from $1.81 per share (loss) to $50.83 per share (loss)).
- The most recent figure is from SPRUCE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: